Cleopatra Hospital is trading 3.53% up at $17.90 after the August 31, 2026 session, with no confirmed company-specific catalyst identified.
- Publicly available coverage shows no new earnings release, acquisition, regulatory action, or material announcement explaining the advance; the latest indexed company news predates the session.
- The broader market was essentially flat, so macro sentiment does not clearly explain the move.